PTC Therapeutics (PTCT) PT Raised to $100 at Credit Suisse Ahead of Data and/or Potential Takeover

February 24, 2015 8:30 AM

Credit Suisse analyst Jason Kantor reiterated an Outperform rating and boosted his price target on PTC Therapeutics (NASDAQ: PTCT) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found